GlassScriptPhysician profile
James Michael Kane
NPI 1568100998
$4,964.26
in general payments reported to CMS, 2019-2025
29 companies · $1,348 in 2025
The $1,348 reported for 2025 was more than what 91% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $300 · 2023: $1,576 · 2024: $1,740 · 2025: $1,348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,015 · Education: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,014.63 |
| Education | $650.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,002.39 | 2022-2025 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $725.85 | 2023-2025 | Gemtesa, Orgovyx |
| Antares Pharma, INC. | $531.90 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Janssen Biotech, INC. | $430.75 | 2023-2025 | Erleada |
| Abbvie INC. | $403.22 | 2023-2025 | |
| Dendreon Pharmaceuticals LLC | $209.45 | 2024-2025 | Provenge |
| Teleflex LLC | $184.12 | 2024 | Urolift, Solesta |
| Coloplast Corp | $183.56 | 2023-2024 | Speedicath |
| Halozyme INC | $180.14 | 2023 | |
| Pfizer INC. | $155.04 | 2023-2025 | |
| Boston Scientific Corporation | $151.44 | 2022-2024 | Rezum Generator, Spaceoar Vue System - 10ml, Lumenis Pulse 120h |
| Endo Pharmaceuticals INC. | $146.19 | 2024 | Xiaflex |
| Amgen INC. | $125.00 | 2023 | Repatha |
| 180 Medical, INC. | $69.08 | 2022-2024 | Cure Catheter |
| Accord Healthcare, INC. | $60.99 | 2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $57.06 | 2023-2025 | Lynparza |
| Merck Sharp & Dohme LLC | $56.60 | 2024-2025 | Keytruda |
| Bayer Healthcare Pharmaceuticals INC. | $41.57 | 2023-2025 | |
| Pacira Pharmaceuticals Incorporated | $41.42 | 2023 | Exparel |
| Endo USA, INC. | $34.17 | 2025 | Xiaflex |
| Tolmar, INC. | $23.65 | 2023 | |
| Olympus America INC. | $23.49 | 2024 | Itind System |
| Procept Biorobotics Corporation | $23.15 | 2023 | Aquabeam Robotic System |
| Blue Earth Diagnostics | $21.21 | 2025 | Posluma |
| C. R. Bard, INC. & Subsidiaries | $18.68 | 2023 | Bard Urinary Drainage Bag |
| Karl Storz Endoscopy-America | $17.86 | 2024 | N.A. |
| Vertex Pharmaceuticals Incorporated | $16.98 | 2024 | |
| Davol INC. | $15.73 | 2025 | Arista |
| Sobi, INC | $13.57 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Kane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.